Press Release

Press Release | Apr 08, 2019

Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today it has provided a $20 million venture loan facility to Encore Dermatology, Inc. (“Encore”), of

Press Release | Apr 02, 2019

Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonide Ointment, USP) and PROMISEB® Topical Cream in the United States from Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius

Press Release | Apr 02, 2019

Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05% and assignment of its rights to market and distribute, PROMISEB® Topical Cream and TRIANEX® 0.05%

Press Release | Feb 26, 2019

The Private Equity Women Investor Network (PEWIN), the pre-eminent organization for senior-level women investment professionals in private equity, today announced that its Members – Adele Oliva (1315 Capital), Hollie Haynes (Luminate Capital Partners), Kristina Heinze (ParkerGale) and Kate Mitchell (Scale Venture Partners) – have each successfully closed a new fund.

Press Release | Feb 07, 2019

Onkos Surgical, Inc. announced today that it has launched MyTray, a fully integrated personal surgical planning solution that leverages preoperative imaging and the precision of surgeon specific procedural requirements; all delivered in the convenience of personalized instrumentation trays. The MyTray solution is powered by the company’s novel digital health platform called uDesign™.

Press Release | Feb 04, 2019

Colorescience®, leading dermatologist-recommended skincare and cosmetics company, is proud to introduce its latest innovation, the Colorescience Total Eye™ Restore Regimen, a comprehensive, 24-hour solution that immediately addresses multiple eye area concerns and provides long-term improvement.

Press Release | Jan 30, 2019

The announcement was made today, at the 15th annual Maui Derm Conference, that Impoyz Cream demonstrated efficacy early, with 14.2% of Impoyz patients achieving treatment success at day 8 versus 1.6% in the vehicle group. Treatment success was achieved when subjects received a “clear” or “almost clear” assessment, marking at least a 2-grade improvement from

Pages 1 2 3 4 6